Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Hexarelin Results After 1 Week: Dosing and Administration Comparison

100mcg once daily (morning fasted) 5–8× baseline amplitude per pulse; cumulative 24-hour GH output +50–60% Moderate. Improved sleep depth and reduced next-day soreness reported in 60–70% of subjects +8–12% from baseline (not statistically significant) High. No

This comparison does not assign a generated winner or score.

  • 100mcg once daily (morning fasted)
  • 5–8× baseline amplitude per pulse; cumulative 24-hour GH output +50–60%
  • Moderate. Improved sleep depth and reduced next-day soreness reported in 60–70% of subjects
  • +8–12% from baseline (not statistically significant)
  • High. No desensitization observed in week one
  • Standard research protocol; maximizes early GH response without receptor saturation
  • 200mcg once daily (morning fasted)
  • 8–12× baseline amplitude per pulse; cumulative 24-hour GH output +80–100%
  • High. Pronounced sleep quality improvements and recovery perception in 75–85% of subjects
  • +10–15% from baseline (approaching clinical relevance threshold)
  • Moderate. Early signs of tachyphylaxis possible by day 6–7
  • Aggressive dosing; produces stronger week-one subjective effects but risks faster receptor desensitization
  • 100mcg twice daily (morning + pre-bed)
  • 6–9× baseline amplitude per pulse; total daily pulses doubled vs once-daily
  • Very high. Sleep architecture changes and recovery improvements in 80–90% of subjects
  • +12–18% from baseline (statistically significant in some cohorts)
  • Low-moderate. Receptor downregulation accelerated by frequent dosing
  • Split dosing mimics natural GH secretion pattern; strongest week-one effects but requires strict timing discipline
  • 100mcg 5 days on, 2 days off
  • 5–8× baseline amplitude on dosing days; no pulse elevation on off days
  • Moderate. Similar to once-daily but with variability during off days
  • +6–10% from baseline (minimal change due to cycling interruption)
  • Very high. Cycling preserves receptor sensitivity for extended protocols
  • Optimal for long-term use; week-one results are slightly blunted but sustainability is maximized
More references

Related material